Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients

Wodarz, Norbert and Rothenhöfer, Christiane and Fischer, Roswitha and Stöber, Gerald and Kiehl, Benno and Jungkunz, Gerd and Riederer, Peter and Klein, Helmfried E. (1998) Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients. PSYCHIATRY RESEARCH, 81 (3). pp. 363-369. ISSN 0165-1781, 1872-7123

Full text not available from this repository.

Abstract

The peripheral-type benzodiazepine receptor (pBZD-R; also called the omega-3 receptor or the mitochondrial benzodiazepine receptor) seems to play a critical role in the production of neurosteroids, which are able to alter the electrical properties of neuronal membranes and thus the firing patterns of neurons. Putative endogenous ligands are the diazepam-binding inhibitor and its processing products, as well as porphyrins, some of them, in the case of porphyria, are well known to give rise to certain aspects of neuropsychiatric disorders, such as schizophrenic-like symptoms. Previous findings of altered benzodiazepine binding sites in post-mortem brain samples and platelets from small samples of schizophrenic patients have been inconclusive. Therefore we investigated characteristic binding parameters (B-max, K-d) of the granulocytic pBZD-R by using the selective ligand PK11.195 in 53 subjects, fulfilling ICD-10 and DSM-IV criteria of schizophrenia. The binding parameters in our total group of 53 schizophrenic patients did not differ from those in healthy subjects. However, B-max values were significantly reduced in schizophrenic patients with predominantly negative symptoms (residual type) compared to schizophrenic patients with predominantly positive symptoms, i.e. paranoid (- 50%) and catatonic subtype (- 38%). Moreover, only residual type schizophrenics exhibited a significantly reduced binding capacity compared to healthy subjects (-38%). More studies are warranted to clarify the functional significance of this binding site in the pathogenesis of negative symptoms. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.

Item Type: Article
Uncontrolled Keywords: OBSESSIVE-COMPULSIVE DISORDER; BINDING-SITES; MONONUCLEAR-CELLS; DIAZEPAM TREATMENT; ANXIOUS PATIENTS; PLATELETS; LIGANDS; BRAIN; MICE; residual schizophrenia; paranoid schizophrenia; catatonic schizophrenia
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 09 Feb 2023 07:19
Last Modified: 09 Feb 2023 07:19
URI: https://pred.uni-regensburg.de/id/eprint/49262

Actions (login required)

View Item View Item